Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soldano Ferrone

Showing results (261-270 of 334) with videos related to

Pageof 34
Sort By:
Cancer Immunology, Immunotherapy : CII|December 20, 2018
Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, ItalyMichele Maio, George Coukos, Soldano Ferrone, et al.
Oncotarget|April 16, 2014
PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutationFrancesco Sabbatino, Yangyang Wang, Xinhui Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Sequential immune escape and shifting of T cell responses in a long-term survivor of melanomaGalina V Yamshchikov, David W Mullins, Chien-Chung Chang, et al.
International Journal of Cancer|September 4, 2019
In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumabSara Caratelli, Roberto Arriga, Tommaso Sconocchia, et al.
Journal of the National Cancer Institute|September 21, 2010
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancerXinhui Wang, Takuya Osada, Yangyang Wang, et al.
Oncotarget|December 15, 2015
Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damageRoberto Arriga, Sara Caratelli, Andrea Coppola, et al.
Molecular Cancer Therapeutics|March 3, 2021
Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T CellsYida Zhang, Lile He, Ananthan Sadagopan, et al.
Cancer Research|March 12, 2009
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cellsMarta Santisteban, Jennifer M Reiman, Michael K Asiedu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2010
NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the scienceMitchell S Cairo, Craig T Jordan, Carlo C Maley, et al.
Cell Death & Disease|April 27, 2024
Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cellsWei Guo, Lin Jia, Ling Xie, et al.
Pageof 34

Showing results (261-270 of 334) with videos related to

Sort By:
Pageof 34
Cancer Immunology, Immunotherapy : CII|December 20, 2018
Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, ItalyMichele Maio, George Coukos, Soldano Ferrone, et al.
Oncotarget|April 16, 2014
PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutationFrancesco Sabbatino, Yangyang Wang, Xinhui Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Sequential immune escape and shifting of T cell responses in a long-term survivor of melanomaGalina V Yamshchikov, David W Mullins, Chien-Chung Chang, et al.
International Journal of Cancer|September 4, 2019
In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumabSara Caratelli, Roberto Arriga, Tommaso Sconocchia, et al.
Journal of the National Cancer Institute|September 21, 2010
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancerXinhui Wang, Takuya Osada, Yangyang Wang, et al.
Oncotarget|December 15, 2015
Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damageRoberto Arriga, Sara Caratelli, Andrea Coppola, et al.
Molecular Cancer Therapeutics|March 3, 2021
Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T CellsYida Zhang, Lile He, Ananthan Sadagopan, et al.
Cancer Research|March 12, 2009
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cellsMarta Santisteban, Jennifer M Reiman, Michael K Asiedu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2010
NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the scienceMitchell S Cairo, Craig T Jordan, Carlo C Maley, et al.
Cell Death & Disease|April 27, 2024
Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cellsWei Guo, Lin Jia, Ling Xie, et al.
Pageof 34